Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth

Yan Dong, Baoping Cao, Meiying Zhang, Weidong Han, James G. Herman, François Fuks, Yali Zhao, Mingzhou Guo

Research output: Contribution to journalArticle

Abstract

Naked cuticle homolog 2 (NKD2) has been reported to antagonize Wnt signaling in zebrafish, mouse and mammals. The aim of this study is to investigate the epigenetic changes and mechanisms of NKD2 in human breast cancer development. Six breast cancer cell lines (MCF-7, ZR75-1, MDA-MB-468, MDA-MB-231, T47D and BT474) and 68 cases of primary human breast cancer were studied using methylation specific PCR, immunohistochemistry, western blot, flow cytometry techniques and a xenograft mouse model. The expression of NKD1 and NKD2 was regulated by promoter region methylation in breast cancer cells. No NKD1 methylation was found in primary human breast cancer. NKD2 was methylated in 51.4% (35/68) of human primary breast cancer samples. NKD2 methylation was significantly associated with reduction of NKD2 expression, and tumor stage (p <0.05). NKD2 suppressed breast cancer cell proliferation both in vitro and in vivo. NKD2 induced G1/S arrest and inhibited Wnt signaling in breast cancer cells. In conclusion, NKD2 is frequently methylated in human breast cancer, and the expression of NKD2 is regulated by promoter region methylation. NKD2 suppresses breast cancer proliferation by inhibiting Wnt signaling.

Original languageEnglish (US)
Pages (from-to)22126-22138
Number of pages13
JournalOncotarget
Volume6
Issue number26
StatePublished - 2015
Externally publishedYes

Fingerprint

Epigenomics
Breast Neoplasms
Growth
Methylation
Genetic Promoter Regions
Zebrafish
Heterografts
Mammals
Flow Cytometry
Western Blotting
Immunohistochemistry
Cell Proliferation
Cell Line
Polymerase Chain Reaction

Keywords

  • Breast cancer
  • DNA methylation
  • Epigenetics
  • NKD2
  • Wnt signaling

ASJC Scopus subject areas

  • Oncology

Cite this

Dong, Y., Cao, B., Zhang, M., Han, W., Herman, J. G., Fuks, F., ... Guo, M. (2015). Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth. Oncotarget, 6(26), 22126-22138.

Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth. / Dong, Yan; Cao, Baoping; Zhang, Meiying; Han, Weidong; Herman, James G.; Fuks, François; Zhao, Yali; Guo, Mingzhou.

In: Oncotarget, Vol. 6, No. 26, 2015, p. 22126-22138.

Research output: Contribution to journalArticle

Dong, Y, Cao, B, Zhang, M, Han, W, Herman, JG, Fuks, F, Zhao, Y & Guo, M 2015, 'Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth', Oncotarget, vol. 6, no. 26, pp. 22126-22138.
Dong Y, Cao B, Zhang M, Han W, Herman JG, Fuks F et al. Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth. Oncotarget. 2015;6(26):22126-22138.
Dong, Yan ; Cao, Baoping ; Zhang, Meiying ; Han, Weidong ; Herman, James G. ; Fuks, François ; Zhao, Yali ; Guo, Mingzhou. / Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth. In: Oncotarget. 2015 ; Vol. 6, No. 26. pp. 22126-22138.
@article{2d24bced210348c7806ada4e1b437244,
title = "Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth",
abstract = "Naked cuticle homolog 2 (NKD2) has been reported to antagonize Wnt signaling in zebrafish, mouse and mammals. The aim of this study is to investigate the epigenetic changes and mechanisms of NKD2 in human breast cancer development. Six breast cancer cell lines (MCF-7, ZR75-1, MDA-MB-468, MDA-MB-231, T47D and BT474) and 68 cases of primary human breast cancer were studied using methylation specific PCR, immunohistochemistry, western blot, flow cytometry techniques and a xenograft mouse model. The expression of NKD1 and NKD2 was regulated by promoter region methylation in breast cancer cells. No NKD1 methylation was found in primary human breast cancer. NKD2 was methylated in 51.4{\%} (35/68) of human primary breast cancer samples. NKD2 methylation was significantly associated with reduction of NKD2 expression, and tumor stage (p <0.05). NKD2 suppressed breast cancer cell proliferation both in vitro and in vivo. NKD2 induced G1/S arrest and inhibited Wnt signaling in breast cancer cells. In conclusion, NKD2 is frequently methylated in human breast cancer, and the expression of NKD2 is regulated by promoter region methylation. NKD2 suppresses breast cancer proliferation by inhibiting Wnt signaling.",
keywords = "Breast cancer, DNA methylation, Epigenetics, NKD2, Wnt signaling",
author = "Yan Dong and Baoping Cao and Meiying Zhang and Weidong Han and Herman, {James G.} and Fran{\cc}ois Fuks and Yali Zhao and Mingzhou Guo",
year = "2015",
language = "English (US)",
volume = "6",
pages = "22126--22138",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "26",

}

TY - JOUR

T1 - Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth

AU - Dong, Yan

AU - Cao, Baoping

AU - Zhang, Meiying

AU - Han, Weidong

AU - Herman, James G.

AU - Fuks, François

AU - Zhao, Yali

AU - Guo, Mingzhou

PY - 2015

Y1 - 2015

N2 - Naked cuticle homolog 2 (NKD2) has been reported to antagonize Wnt signaling in zebrafish, mouse and mammals. The aim of this study is to investigate the epigenetic changes and mechanisms of NKD2 in human breast cancer development. Six breast cancer cell lines (MCF-7, ZR75-1, MDA-MB-468, MDA-MB-231, T47D and BT474) and 68 cases of primary human breast cancer were studied using methylation specific PCR, immunohistochemistry, western blot, flow cytometry techniques and a xenograft mouse model. The expression of NKD1 and NKD2 was regulated by promoter region methylation in breast cancer cells. No NKD1 methylation was found in primary human breast cancer. NKD2 was methylated in 51.4% (35/68) of human primary breast cancer samples. NKD2 methylation was significantly associated with reduction of NKD2 expression, and tumor stage (p <0.05). NKD2 suppressed breast cancer cell proliferation both in vitro and in vivo. NKD2 induced G1/S arrest and inhibited Wnt signaling in breast cancer cells. In conclusion, NKD2 is frequently methylated in human breast cancer, and the expression of NKD2 is regulated by promoter region methylation. NKD2 suppresses breast cancer proliferation by inhibiting Wnt signaling.

AB - Naked cuticle homolog 2 (NKD2) has been reported to antagonize Wnt signaling in zebrafish, mouse and mammals. The aim of this study is to investigate the epigenetic changes and mechanisms of NKD2 in human breast cancer development. Six breast cancer cell lines (MCF-7, ZR75-1, MDA-MB-468, MDA-MB-231, T47D and BT474) and 68 cases of primary human breast cancer were studied using methylation specific PCR, immunohistochemistry, western blot, flow cytometry techniques and a xenograft mouse model. The expression of NKD1 and NKD2 was regulated by promoter region methylation in breast cancer cells. No NKD1 methylation was found in primary human breast cancer. NKD2 was methylated in 51.4% (35/68) of human primary breast cancer samples. NKD2 methylation was significantly associated with reduction of NKD2 expression, and tumor stage (p <0.05). NKD2 suppressed breast cancer cell proliferation both in vitro and in vivo. NKD2 induced G1/S arrest and inhibited Wnt signaling in breast cancer cells. In conclusion, NKD2 is frequently methylated in human breast cancer, and the expression of NKD2 is regulated by promoter region methylation. NKD2 suppresses breast cancer proliferation by inhibiting Wnt signaling.

KW - Breast cancer

KW - DNA methylation

KW - Epigenetics

KW - NKD2

KW - Wnt signaling

UR - http://www.scopus.com/inward/record.url?scp=84941243535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941243535&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84941243535

VL - 6

SP - 22126

EP - 22138

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 26

ER -